keyword
https://read.qxmd.com/read/38651406/case-series-efficacy-of-polyclonal-intravenous-immunoglobulin-for-refractory-clostridioides-difficile-infection
#1
JOURNAL ARTICLE
Sophie A Ragan, Caitlin Doyle, Neha Datta, Heather Abdic, Mark H Wilcox, Ros Montgomery, Shanika A Crusz, Yashwant R Mahida, Tanya M Monaghan
BACKGROUND: Intravenous immunoglobulin (IVIg) for Clostridioides difficile infection (CDI) no longer features in treatment guidelines. However, IVIg is still used by some clinicians for severe or recurrent CDI (rCDI) cases. The main objective of this study was to investigate the efficacy of IVIg and to identify possible predictors of disease resolution post IVIg administration for patients with CDI. METHODS: This retrospective observational cohort study of patients ≥2 years old hospitalised with severe, relapsing, or rCDI treated with IVIg therapy was performed in a large UK tertiary hospital between April 2018 and March 2023...
April 1, 2024: Antibodies
https://read.qxmd.com/read/38650992/primary-catastrophic-antiphospholipid-syndrome-in-children-with-midbrain-infarction-a-case-report
#2
Qinghua Dong, Jianyun Yin, Hang Su, Qian Ni
BACKGROUND: Catastrophic antiphospholipid syndrome (CAPS) is a multi-system autoimmune disease characterized by extensive thrombosis. Pediatric CAPS is extremely rare and associated with a high mortality rate, especially when midbrain infarction is involved. Hence, early diagnosis and prompt initiation of appropriate treatment for CAPS complicated by midbrain infarction are of utmost importance in achieving favorable outcomes. CASE PRESENTATION: In this report, we present the case of a 14-year-old girl who presented with neurological symptoms and digestive system infection and was initially diagnosed with an "intracranial infection"...
2024: Frontiers in Pediatrics
https://read.qxmd.com/read/38644607/a-case-of-immunotherapy-responsive-autoimmune-hemichorea
#3
Rachel E Rodin, Nagagopal Venna, Denis T Balaban
INTRODUCTION: Subacute adult-acquired hemichorea is a striking presentation with a broad differential, including ischemic, metabolic, and inflammatory causes. CASE: We encountered a 74-year-old woman with rapid onset of hemichorea and associated encephalopathy. Following a thorough workup without identification of clear imaging or laboratory abnormalities, we empirically treated with IVIg. Her hemichorea dramatically improved. Due to relapses of hemichorea, she required repeat immunotherapy with IVIg or high dose steroids followed by maintenance mycophenolate...
April 21, 2024: Annals of Clinical and Translational Neurology
https://read.qxmd.com/read/38644032/cytokine-storm-in-chikungunya-can-we-call-it-multisystem-inflammatory-syndrome-associated-with-chikungunya
#4
Zoilo Morel, Tamara Martínez, Fernando Galeano, Judith Coronel, Lorena Quintero, Rolando Jimenez, Jorge Ayala, Sara Amarilla, Dolores Lovera, Celia Martínez de Cuellar
Paraguay is currently facing a new outbreak of Chikungunya virus. This report summarizes two severe cases of Chikungunya (CHIKV) infection, confirmed by real-time reverse transcription polymerase chain reaction. We present the cases of patients with acute CHIKV infection and multisystem involvement, with fever, rash, abdominal pain, vomiting, myocarditis, and coronary artery anomalies, very similar to the cases described in MIS-C related to SARS-CoV-2 during the COVID-19 Pandemic. Both patients received IVIG and methylprednisolone, with good clinical response...
April 2024: Reumatología clinica
https://read.qxmd.com/read/38638794/immune-thrombocytopenic-purpura-associated-with-systemic-lupus-erythematosus-helicobacter-pylori-and-hepatitis-b
#5
Bamidele O Johnson, Amisha Nimawat, Nyier W Doar, Thi Nguyen, Malar Thwin
Immune thrombocytopenic purpura (ITP) is a hematologic condition characterized by decreased circulating platelets, resulting in bruising, bleeding gums, and internal bleeding. This disorder can be categorized into two primary forms based on the duration of symptoms and underlying causes. Acute ITP primarily affects young children, typically between the ages of two and six, but it can also impact older children and adults. Viral infections like chickenpox, respiratory infections, or gastroenteritis often precede it...
March 2024: Curēus
https://read.qxmd.com/read/38634891/challenges-in-the-treatment-of-pediatric-mycoplasma-pneumoniae-pneumonia
#6
REVIEW
Guodong Ding, Xiaobo Zhang, Angela Vinturache, Annemarie M C van Rossum, Yong Yin, Yongjun Zhang
UNLABELLED: Mycoplasma pneumoniae (MP) is an important cause of community-acquired pneumonia in children and young adolescents. Despite macrolide antibiotics effectiveness as a first-line therapy, persistence of fever and/or clinical deterioration sometimes may complicate treatment and may even lead to severe systemic disease. To date, there is no consensus on alternative treatment options, optimal dosage, and duration for treating severe, progressive, and systemic MP pneumonia after macrolide treatment failure...
April 18, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38634529/paraneoplastic-calmodulin-kinase-like-vesicle-associated-protein-camkv-autoimmune-encephalitis
#7
JOURNAL ARTICLE
Michael Gilligan, Connie E Lesnick, Yong Guo, Michael J Bradshaw, Shafeeq S Ladha, Mihaela Nowak, Maulik P Shah, John R Wittenborn, Eati Basal, Shannon Hinson, Binxia Yang, Divyanshu Dubey, John R Mills, Sean J Pittock, Anastasia Zekeridou, Andrew McKeon
OBJECTIVES: To report an autoimmune paraneoplastic encephalitis characterized by immunoglobulin G (IgG) antibody targeting synaptic protein calmodulin kinase-like vesicle-associated (CAMKV). METHODS: Serum and cerebrospinal fluid (CSF) samples harboring unclassified antibodies on murine brain-based indirect immunofluorescence assay (IFA) were screened by human protein microarray. In 5 patients with identical cerebral IFA staining, CAMKV was identified as top-ranking candidate antigen...
April 18, 2024: Annals of Neurology
https://read.qxmd.com/read/38634003/a-retrospective-observational-study-on-characteristics-treatment-patterns-and-healthcare-resource-use-of-patients-with-myasthenia-gravis-in-england
#8
JOURNAL ARTICLE
Jordy van Enkhuizen, Jean Binns, April Betts, Fatemeh Saberi Hosnijeh, Myriam Alexander, Mark McCormack, Saiju Jacob
BACKGROUND: There are limited data on the real-world healthcare resource use (HCRU) and management costs of myasthenia gravis (MG) in England. OBJECTIVE: This study aims to assess the burden of disease for patients with MG in England. DESIGN: A retrospective, observational cohort study of adult patients diagnosed with MG, using data from the Hospital Episode Statistics data warehouse. METHODS: Patients with a first-ever recorded diagnosis of MG between 30 June 2015 and 30 June 2020 were followed up until 30 June 2021 or death, whichever occurred first...
2024: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38633948/navigating-treatment-dilemmas-recalcitrant-pemphigus-and-the-burden-of-multiple-comorbidities
#9
Priya Garg, Kshitiz Lakhey, Nishtha Mishra, Yash Buccha, Kirti S Deo
Pemphigus vulgaris is a chronic autoimmune disease of the skin caused by the production of autoantibodies targeting desmogleins 1 and 3 usually presenting in individuals with an average age of onset of approximately 40 years. A 35-year-old obese, diabetic woman presented with fluid-filled lesions over her body for three months along with erosions and painful ulcers in her mouth and genital area for two months. Based on clinical and histopathological studies, the patient was diagnosed as a case of pemphigus vulgaris...
March 2024: Curēus
https://read.qxmd.com/read/38630952/case-control-study-of-individuals-with-small-fiber-neuropathy-after-covid-19
#10
JOURNAL ARTICLE
Lindsay McAlpine, Adeel S Zubair, Phillip Joseph, Serena Spudich
OBJECTIVES: To report a case-control study of new-onset small fiber neuropathy (SFN) after COVID-19 with invasive cardiopulmonary exercise testing (iCPET). SFN is a critical objective finding in long COVID and amenable to treatment. METHODS: A retrospective chart review was conducted on patients seen in the NeuroCOVID Clinic at Yale who developed new-onset SFN after a documented COVID-19 illness. We collected demographics, symptoms, skin biopsy, iCPET testing, treatments, and clinical response to treatment or no intervention...
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38630951/post-covid-small-fiber-neuropathy-implications-of-innate-immunity-and-challenges-on-ivig-therapy
#11
EDITORIAL
Marinos C Dalakas
No abstract text is available yet for this article.
May 2024: Neurology® Neuroimmunology & Neuroinflammation
https://read.qxmd.com/read/38627111/protective-effect-of-breastfeeding-on-kawasaki-disease-a-systemic-review-and-meta-analysis
#12
REVIEW
Wan-Jung Yang, Wen-Hsien Lu, Yu-Yang Hsiao, Tien-Wei Hsu, Yee-Hsuan Chiou
BACKGROUND: Previous research has indicated a negative correlation between exclusive breastfeeding and the incidence of Kawasaki disease (KD). However, the validation of this discovery through meta-analytical studies has been lacking. Furthermore, uncertainties persist regarding whether breastfeeding reduces the risk of coronary artery lesions (CAL) or resistance to intravenous immunoglobulin (IVIG). METHODS: A systematic exploration of the MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, and ClinicalTrials...
April 15, 2024: Pediatrics and Neonatology
https://read.qxmd.com/read/38618469/a-comparative-review-of-typical-and-atypical-optic-neuritis-advancements-in-treatments-diagnostics-and-prognosis
#13
REVIEW
Noah J Spillers, Patrick M Luther, Norris C Talbot, Evan J Kidder, Connor A Doyle, Salim C Lutfallah, Alyssa G Derouen, Sridhar Tirumala, Shahab Ahmadzadeh, Sahar Shekoohi, Alan D Kaye, Giustino Varrassi
Optic neuritis (ON) is a debilitating condition that through various mechanisms, including inflammation or demyelination of the optic nerve, can result in partial or total permanent vision loss if left untreated. Accurate diagnosis and promptly initiated treatment are imperative related to the potential of permanent loss of vision if left untreated, which can lead to a significant reduction in the quality of life in affected patients. ON is subtyped as "typical" or "atypical" based on underlying causative etiology...
March 2024: Curēus
https://read.qxmd.com/read/38618457/miller-fisher-syndrome-following-influenza-a-infection
#14
Shiho Mitsuhashi, Asuka Suzuki, Koji Hayashi, Mamiko Sato, Yuka Nakaya, Naoko Takaku, Yasutaka Kobayashi
Miller-Fisher syndrome (MFS), characterized by ophthalmoplegia, ataxia, and areflexia, is a Guillain-Barré syndrome (GBS) variant. It is well-known that the causative antibody for MFS is anti-GQ1b antibody. This report describes a rare case of MFS with not only anti-GQ1b antibodies but also anti-GT1a antibodies following Influenza A infection. The patient, a 47-year-old woman, contracted Influenza A three weeks before admission. She complained of double vision followed by areflexia, ataxia in the four extremities, and complete gaze palsy...
March 2024: Curēus
https://read.qxmd.com/read/38618393/multisystem-inflammatory-syndrome-in-adults-related-unstable-angina-with-coronary-aneurysm-in-a-young-female-a-case-report
#15
Hiroki Aihara
Multisystem inflammatory syndrome in adults (MIS-A) is a systemic inflammatory disease associated with COVID-19 and follows coronary artery aneurysms similar to Kawasaki disease. In many cases, it is improved by treatments such as high-dose steroids or intravenous immunoglobulin (IVIg). However, the role of untreated coronary artery aneurysms leading to future stenosis remains unknown. Untreated MIS-A may potentially lead to the formation of coronary aneurysms. In cases of COVID-19 where young adults present with angina-like symptoms, an evaluation for angina is considered...
March 2024: Curēus
https://read.qxmd.com/read/38615825/intravenous-immunoglobulin-therapy-for-covid-19-in-immunocompromised-patients-a-retrospective-cohort-study
#16
JOURNAL ARTICLE
Remigius Gröning, Jonatan Walde, Clas Ahlm, Mattias Ne Forsell, Johan Normark, Johan Rasmuson
OBJECTIVES: To investigate the effectiveness of intravenous immunoglobulin (IVIG) as treatment for COVID-19 in immunocompromised patients. METHODS: This retrospective study investigated outcomes for immunocompromised, vaccine non-responsive, patients that between September 2022 and April 2023 received IVIG as treatment for COVID-19 in the region of Västerbotten, Sweden. We analyzed clinical data, viral load, and anti-SARS-CoV-2 IgG binding and neutralization levels of patient serum samples and IVIG production batches...
April 12, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38614658/secondary-hemophagocytic-lymphohistiocytosis-an-unusual-complication-in-disseminated-mycobacterium-tuberculosis
#17
Shan Kai Ing, Grace Wan Chieng Lee, Tze Shin Leong, Yih Hoong Lee, George Yew Liang Lau, Nur Nazihah Yusof, Andrew Kean Wei Chang, Kelly Kee Yung Wong
Tuberculosis-associated hemophagocytic lymphohistiocytosis (TB-HLH) is a rare and life-threatening complication of tuberculosis infection. Early recognition and treatment of TB-HLH is crucial for improving outcomes. Treatment typically involves a combination of antituberculosis therapy and immunosuppressive therapy to control the immune system's overreaction. In this report, we present the case of a 53-year-old ambulance driver who was diagnosed with TB-HLH. His CT scan revealed splenic abscesses, hepatomegaly and bilateral lung consolidation...
July 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38610057/c-reactive-protein-to-albumin-ratio-as-a-prognostic-tool-for-predicting-intravenous-immunoglobulin-resistance-in-children-with-kawasaki-disease-a-systematic-review-of-cohort-studies
#18
REVIEW
Jue Liu, Xingguang Chen, Minling Yang, Fangfang Shen, Feng Zhu, Jian Jin, Yiqun Teng
BACKGROUND: Intravenous immunoglobulin (IVIG) is the primary treatment for Kawasaki disease (KD). However, 10-20% of KD patients show no response to IVIG treatment, making the early prediction of IVIG resistance a key focus of KD research. Our aim is to explore the application of the C-reactive protein to albumin ratio (CAR) for predicting IVIG resistance in children with KD through meta-analysis. METHODS: Cochrane Library, PubMed, MEDLINE, EMbase, CNKI, WanFang, the Chinese Biomedical Database, and CQVIP were searched up to November 2023 for cohort studies on predicting IVIG-resistant KD using the CAR...
April 12, 2024: Pediatric Rheumatology Online Journal
https://read.qxmd.com/read/38608119/transverse-spinal-cord-infarction-following-immunoglobulin-treatment-in-a-patient-with-exfoliative-dermatitis-a-case-report
#19
JOURNAL ARTICLE
Lili Zhang, Lanying He, Jing Huang, Sixie Ren, Jian Wang
RATIONALE: Transverse spinal cord infarction (SCI) is rare but highly disabling. Aortic thrombosis was described as one of the most common etiologies. Thromboembolic complications associated with intravenous immunoglobulin (IVIG) have been reported. PATIENT CONCERNS: A previously well, 64-year-old man who was given the treatment of IVIG (0.4 g/kg/d for 5 days) for exfoliative dermatitis 2 weeks before, progressively developed flaccid paraplegia of lower extremities, loss of all sensations below T3 level and urinary incontinence within 50 minutes...
April 12, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38605438/the-second-international-consensus-guidelines-on-the-management-of-bk-polyomavirus-in-kidney-transplantation
#20
JOURNAL ARTICLE
Camille N Kotton, Nassim Kamar, David Wojciechowski, Michael Eder, Helmut Hopfer, Parmjeet Randhawa, Martina Sester, Patrizia Comoli, Helio Tedesco Silva, Greg Knoll, Daniel C Brennan, Jennifer Trofe-Clark, Lars Pape, David Axelrod, Bryce Kiberd, Germaine Wong, Hans H Hirsch
BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation. International experts reviewed current evidence and updated recommendations according to Grading of Recommendations, Assessment, Development, and Evaluations (GRADE). Risk factors for BKPyV-DNAemia and biopsy-proven BKPyV-nephropathy include recipient older age, male sex, donor BKPyV-viruria, BKPyV-seropositive donor/-seronegative recipient, tacrolimus, acute rejection, and higher steroid exposure. To facilitate early intervention with limited allograft damage, all kidney transplant recipients should be screened monthly for plasma BKPyV-DNAemia loads until month 9, then every 3 mo until 2 y posttransplant (3 y for children)...
April 12, 2024: Transplantation
keyword
keyword
5935
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.